Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Melillo

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Oncogene|April 21, 2001
The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to RetR M Melillo, F Carlomagno, G De Vita, et al.
Annales D'Endocrinologie|April 23, 2003
Genetic alterations in differentiated thyroid cancer: what can be expected for gene expression profiling of thyroid carcinomasM Santoro, R M Melillo, F Carlomagno, et al.
Biochimie|July 13, 1999
Different mutations of the RET gene cause different human tumoral diseasesM Santoro, R M Melillo, F Carlomagno, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 23, 1998
Expression of the RET/PTC1 oncogene impairs the activity of TTF-1 and Pax-8 thyroid transcription factorsG De Vita, M Zannini, A M Cirafici, et al.
Molecular and Cellular Biology|June 8, 2001
Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascadeR M Melillo, M Santoro, S H Ong, et al.
Journal of Internal Medicine|July 29, 1998
Molecular biology of the MEN2 geneM Santoro, R M Melillo, F Carlomagno, et al.
Oncology Research|May 23, 2000
Human N-ras, TRK-T1, and RET/PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cellsG Portella, D Vitagliano, C Borselli, et al.
Current Pharmaceutical Design|May 17, 2018
Role of Formyl Peptide Receptors in Gastrointestinal HealingN Prevete, A de Paulis, D Sgambato, et al.
Cancer Research|February 1, 1997
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotypeF Carlomagno, G Salvatore, A M Cirafici, et al.
Oncogene|January 27, 2015
Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathwayC Visciano, F Liotti, N Prevete, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Oncogene|April 21, 2001
The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to RetR M Melillo, F Carlomagno, G De Vita, et al.
Annales D'Endocrinologie|April 23, 2003
Genetic alterations in differentiated thyroid cancer: what can be expected for gene expression profiling of thyroid carcinomasM Santoro, R M Melillo, F Carlomagno, et al.
Biochimie|July 13, 1999
Different mutations of the RET gene cause different human tumoral diseasesM Santoro, R M Melillo, F Carlomagno, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 23, 1998
Expression of the RET/PTC1 oncogene impairs the activity of TTF-1 and Pax-8 thyroid transcription factorsG De Vita, M Zannini, A M Cirafici, et al.
Molecular and Cellular Biology|June 8, 2001
Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascadeR M Melillo, M Santoro, S H Ong, et al.
Journal of Internal Medicine|July 29, 1998
Molecular biology of the MEN2 geneM Santoro, R M Melillo, F Carlomagno, et al.
Oncology Research|May 23, 2000
Human N-ras, TRK-T1, and RET/PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cellsG Portella, D Vitagliano, C Borselli, et al.
Current Pharmaceutical Design|May 17, 2018
Role of Formyl Peptide Receptors in Gastrointestinal HealingN Prevete, A de Paulis, D Sgambato, et al.
Cancer Research|February 1, 1997
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotypeF Carlomagno, G Salvatore, A M Cirafici, et al.
Oncogene|January 27, 2015
Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathwayC Visciano, F Liotti, N Prevete, et al.
Pageof 4